Back to Search
DELFINA BUR, MD
MD
Dermatology Physician
NPI: 1518600352Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
BP10079070(TX)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
BP20083923(TX)
Research & Publications (20)
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
PMID 19358611·J Med Chem·2009
8-other
Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.
PMID 18604229·Br J Pharmacol·2008
4-observational
Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.
PMID 18408886·Cell Mol Life Sci·2008
7-preclinical
Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
PMID 17918177·ChemMedChem·2008
7-preclinical
Characterization of recombinant CDR1, an Arabidopsis aspartic proteinase involved in disease resistance.
PMID 17650510·J Biol Chem·2007
8-other
N-terminal extension of the yeast IA3 aspartic proteinase inhibitor relaxes the strict intrinsic selectivity.
PMID 17608726·FEBS J·2007
8-other
Key features determining the specificity of aspartic proteinase inhibition by the helix-forming IA3 polypeptide.
PMID 17145748·J Biol Chem·2007
8-other
Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.
PMID 17091526·ChemMedChem·2006
7-preclinical
Inhibitors of Plasmepsin II-potential antimalarial agents.
PMID 17000102·Bioorg Med Chem Lett·2006
7-preclinical
Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn.
PMID 16895485·Biol Chem·2006
8-other
Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV.
PMID 16502446·Angew Chem Int Ed Engl·2006
7-preclinical
Molecular analysis of the interaction between cardosin A and phospholipase D(alpha). Identification of RGD/KGE sequences as binding motifs for C2 domains.
PMID 16279943·FEBS J·2005
8-other
X-ray structure of plasmepsin II complexed with a potent achiral inhibitor.
PMID 15840589·J Biol Chem·2005
7-preclinical
Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists.
PMID 15139756·J Med Chem·2004
7-preclinical
De Novo design, synthesis, and in vitro evaluation of a new class of nonpeptidic inhibitors of the malarial enzyme plasmepsin II.
PMID 12404641·Chembiochem·2002
7-preclinical
Tris-benzimidazole derivatives: design, synthesis and DNA sequence recognition.
PMID 11597472·Bioorg Med Chem·2001
8-other
A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
PMID 11438756·Protein Eng·2001
7-preclinical
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
PMID 11384231·J Med Chem·2001
8-other
The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae.
PMID 11042188·J Biol Chem·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4900 N IH 35 STE 2.404
AUSTIN, TX 78751 - Phone
- (512) 324-9999
Quick Facts
- NPI
- 1518600352
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile